Ivax Glucovance generic approved
Executive Summary
FDA approves Ivax' ANDA for generic version of Bristol-Myers Squibb's Glucovance (glyburide/metformin) with 180 days of marketing exclusivity Feb. 18. Ivax says it is building inventory for launch. Glucovance lost marketing exclusivity Jan. 31. Ivax is in the middle of 180-day exclusivity for metformin extended-release (Bristol's Glucophage XR) (1"The Pink Sheet" Dec. 1, 2003, p. 17)...